Key result
Wearable heart rate monitoring studies in CVD predominantly rely on zone analysis, averaging ~71% methodological quality.
Why the study?
Wearable heart rate monitoring can continuously assess physical activity, but methods translating heart rate data into clinically meaningful physical activity metrics in adults with cardiovascular disease or risk factors remain diverse and poorly standardised.
Does wearable heart rate monitoring quantify physical activity behaviour and estimate physiological outcomes in adults with cardiovascular disease or related risk factors?
Systematic Review
Does wearable heart rate monitoring quantify physical activity behaviour and estimate physiological outcomes in adults with cardiovascular disease or related risk factors?
This systematic review identifies four main approaches for translating wearable heart rate data into physical activity metrics in cardiovascular care, highlighting the urgent need for standardized definitions, algorithm transparency, and prospective clinical validation.
Background/Introduction Heart rate monitoring by wearable devices could offer a physiological, personalised and continuous way to assess physical activity duration and intensity. However, methods that translate heart rate data into clinically meaningful physical activity metrics remain diverse and poorly standardised. Purpose To describe and classify how wearable heart rate data are used to quantify physical activity behaviour and to estimate physiological outcomes in adults with cardiovascular disease or related risk factors. Methods Following PRISMA guidelines, a systematic search was performed in PubMed, Web of Science, and CENTRAL for studies published between 2014 and April 2024. Eligible studies included adults with cardiovascular disease or related risk factors wearing wrist or chest heart rate monitors to estimate physical activity metrics or related physiological outcomes. Two reviewers screened records and extracted data. Findings were synthesised narratively. Methodological quality and risk of bias were assessed using the Crowe Critical Appraisal Tool. Results From 828 records, 20 studies met inclusion criteria (Figure 1). Twelve studies used wrist worn devices, seven used chest straps, and one did not specify device type. We identified four heart rate based estimation approaches (Figure 2): (1) heart rate zone analysis (14/20), quantifying time in moderate to vigorous zones to assess guideline or training adherence, but using heterogeneous definitions for maximum and resting heart rate; (2) physiological modelling (4/20), estimating outcomes such as energy expenditure indicators (physical activity level) or cardiorespiratory fitness (VO2max), often with limited reporting of model parameters; (3) change detection (1/20), using time series and machine learning techniques to detect shifts in activity behaviour over time; and (4) a derived personalised scoring system (1/20), translating intensity and duration into a single feedback score. Crowe scores ranged from 50% to 87% (mean 71%). Across approaches, external validation and reproducible reporting were frequently limited. Conclusions Heart rate based physical activity estimation holds the promise of physiologically meaningful and personalised physical activity monitoring in cardiovascular disease care. Modelling approaches and personalised scoring systems that link physical activity behaviour to cardiovascular outcomes may provide much needed clinical tools for physical activity management in patients. In a rapidly evolving wearable technology landscape, future research should prioritise standardised definitions, algorithm transparency, and prospective clinical validation.
No takes yet. Share an insight, caveat, or question.
Vermunicht et al. (2026) conducted a systematic review in Cardiovascular disease or related risk factors. Wearable heart rate monitoring (wrist-worn devices or chest straps) was evaluated on Heart rate-based physical activity estimation approaches and methodological quality (Crowe Critical Appraisal Tool score). Wearable heart rate monitoring across 20 CVD studies mostly used zone analysis (14/20) or physiological modelling (4/20), with mean quality scores of 71% (range 50%-87%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: